Population-based screening for family history of end-stage renal disease among incident dialysis patients

被引:90
作者
Freedman, BI
Volkova, NV
Satko, SG
Krisher, J
Jurkovitz, C
Soucie, JM
McClellan, WM
机构
[1] Wake Forest Univ, Nephrol Sect, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA
[2] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[3] SE Kidney Council Inc, ESRD Network 6, Raleigh, NC USA
[4] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA
关键词
chronic kidney disease; African Americans; hypertension; diabetes mellitus;
D O I
10.1159/000088491
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: We determined the familial aggregation of end-stage renal disease (ESRD) in a large, population-based sample of incident ESRD cases to assess the feasibility of developing a targeted screening and prevention program directed at members of families at high risk for kidney disease. Methods: Between January 1, 1995, and December 31, 2003, incident dialysis patients in ESRD Network 6 facilities were asked to complete a voluntary questionnaire on family history (FH) of ESRD. Cases with ESRD attributed to Mendelian diseases or urologic causes were excluded. FH was considered present if first- or second-degree relatives had ESRD. Deidentified FH data were collated with demographic data at dialysis initiation. Results: More than 46% of eligible patients (25,883/55,929) provided FH information and 22.8% (5,901/25,883) of these reported having a FH of ESRD. FH of ESRD was positively associated with female gender, earlier age at ESRD onset, and primary cause of ESRD, and negatively associated with white race. FH associations with age, race, gender, and primary cause of renal failure remained statistically significant after simultaneous adjustment in a multivariate logistic regression model. Conclusions: Approximately 23% of incident dialysis patients have close relatives with ESRD. Far more are likely to have relatives with clinically silent proteinuria or chronic kidney disease (CKD), both risk factors for future cardiovascular events and ESRD. Physicians caring for patients with CKD should be aware of the marked familial aggregation of ESRD and consider focusing screening efforts on high-risk family members in an attempt to slow the exponential growth rate of kidney disease. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:529 / 535
页数:7
相关论文
共 18 条
[1]   Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease [J].
Bergman, S ;
Key, BO ;
Kirk, KA ;
Warnock, DG ;
Rostand, SG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :341-346
[2]   Screening for proteinuria in US adults - A cost-effectiveness analysis [J].
Boulware, LE ;
Jaar, BG ;
Tarver-Carr, ME ;
Brancati, FL ;
Powe, NR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23) :3101-3114
[3]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[4]   A FAMILIAL RISK OF CHRONIC RENAL-FAILURE AMONG BLACKS ON DIALYSIS [J].
FERGUSON, R ;
GRIM, CE ;
OPGENORTH, TJ .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (12) :1189-1196
[5]  
Freedman BI, 1997, J AM SOC NEPHROL, V8, P1942
[6]   Health-related quality of life among dialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study [J].
Fukuhara, S ;
Lopes, AA ;
Bragg-Gresham, JL ;
Kurokawa, K ;
Mapes, DL ;
Akizawa, T ;
Bommer, J ;
Canaud, BJ ;
Port, FK ;
Held, PJ .
KIDNEY INTERNATIONAL, 2003, 64 (05) :1903-1910
[7]   Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition - A patient-level meta-analysis [J].
Jafar, TH ;
Stark, PC ;
Schmid, CH ;
Landa, M ;
Maschio, G ;
de Jong, PE ;
de Zeeuw, D ;
Shahinfar, S ;
Toto, R ;
Levey, AS .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (04) :244-252
[8]   Family members of patients treated for ESRD have high rates of undetected kidney disease [J].
Jurkovitz, C ;
Franch, H ;
Shoham, D ;
Bellenger, J ;
McClellan, W .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (06) :1173-1178
[9]   Cumulative risk for developing end-stage renal disease in the US population [J].
Kiberd, BA ;
Clase, CM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06) :1635-1644
[10]   Effect of end-stage renal disease on the quality of life of older patients [J].
Loos, C ;
Briançon, S ;
Frimat, L ;
Hanesse, B ;
Kessler, M .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (02) :229-233